950 — Lees Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00- HK$624.17m
- HK$438.96m
- HK$1.44bn
Brief: Lee's Pharmaceutical Holdings Says Qtrly Profit Attributable HK$42.1 Mln
Brief: Lee's Pharmaceutical Holdings Says Unit To Advance Shareholder Loan
Brief: Lee's Pharmaceutical Holdings Says Unit Successfully Completed Phase II Trial Of Cyclosporine A Ophthalmic Gel In China
HK-listed Lee's Pharmaceutical hits near 5-week high on buyback plan
Brief: Lee's Pharmaceutical Holdings Says Co Decides To Implement Share Repurchase Program Of Up To 30 Mln Shares
Brief: Lee's Pharmaceutical Sees HY Net Profit Between Hk$31.4-44.0 Mln
Brief: Lee's Pharmaceutical Holdings Says Idmc Recommends Discontinuation Of Trial For Liver Cancer Treatment
Brief: Lee's Pharmaceutical Holdings Posts QTRLY Revenue HK$282.9 MLN
Brief: Lee's Pharmaceutical Holdings Sells 45.5 Pct Stake In China Ophthalmology Focus
Brief: Lee's Pharmaceutical Holdings Recommends Payment Of Final Dividend Of Hk8.4 Cents Per Share
Drug maker Lee's Pharmaceutical hits 6-month high on strong forecast
Brief: Lee's Pharmaceutical Holdings Issues Profit Warning
Brief: Lee's Pharmaceutical Says China Oncology Focus Entered Licensing Agreement With Auransa
Brief: Auransa Enters Exclusive Licensing Agreement With China Oncology Focus Limited
Brief: Lee's Pharmaceutical's Unit To Lend Principal Amount Of Hk$4 Mln To Powder Pharmaceuticals Inc
Brief: Lee's Pharmaceutical Holdings Posts Qtrly Profit Attributable Of HK$71.7 Mln
Brief: Lee's Pharmaceutical Says Unit & Perfect Concept Holdings Subscribed Shares Of China Oncology Focus
Brief: Lee's Pharmaceutical Holdings Says Unit To Advance Shareholder Loan In Principal Amount Hk$3 Mln
Brief: Lee's Pharmaceutical Holdings Posts Qtrly Profit Attributable Of HK$55.6 Mln